Genesis Healthcare plan takes effect after nursing home sale closes, built on a $150 million settlement
ElevenFlo ·
Genesis Healthcare's sale-based plan took effect for all remaining debtors on October 23, 2026, and existing equity was cancelled. Administrative claims against the non-ACO debtors are due November 23 and final fee applications by December 22 Dkt. 3702. The committee's lead counsel has already asked for $23.2 million in fees, with objections due December 7 Dkt. 3779.
Jump to section
The second amended plan was confirmed on October 14, 2026 and took effect for all remaining debtors on October 23. Substantially all operations went to 101 W. State Street Holdings, and a liquidation trust and a wind-down trust now administer what is left.
Genesis Healthcare's second amended joint chapter 11 plan took effect for all remaining debtors on October 23, 2026, and existing Genesis common equity was cancelled Dkt. 3702. Judge Stacey G.C. Jernigan had confirmed the plan on October 14. The confirmation order overruled every objection that had not been withdrawn or settled and authorized the ACO transaction as part of the sale Dkt. 3662. The plan took effect that same day for LTC ACO, LLC and PAI Participant 1, LLC Dkt. 3667. Counsel to one of the patient care ombudsmen reports that the sale of substantially all assets to 101 W. State Street Holdings LLC also closed on October 14 Dkt. 3776.
The confirmed plan follows the sale path. Welltower's and Omega's term loan claims are allowed at $233.19 million of principal plus applicable accruals and are paid in full in cash. General unsecured creditors share in trust assets through four distribution groups. Convenience claims receive 50% from a $1.5 million reserve. At the center of the plan is a $150 million Plan Settlement Amount. The settling parties may provide it in cash, through debt reduction or the forgiveness or assignment of claims, by giving up CPE deal-protection amounts, or by a combination of these Dkt. 3635. Once the sale closed, the disputed WAX and MAO term loan claims were cancelled without distribution Dkt. 3550. Subordinated claims, which include ReGen's convertible notes, and existing equity receive nothing Dkt. 3070.
What remains is administration. The GHC Liquidation Trust is funded with $10 million and directed by a five-person board chosen by the creditors' committee. It pursues the assigned causes of action and handles claims Dkt. 3635. Administrative and administrative PL/GL claims against the debtors other than the ACO entities are due November 23, 2026, and final professional fee applications are due December 22, 2026 Dkt. 3702. The matching administrative claims deadline for the ACO entities passed on November 13 Dkt. 3667. The same day, the trust opposed a motion to allow a claim filed nearly a year after the October 31, 2025 general bar date Dkt. 3771. Among the final fee applications filed so far, the largest is from the committee's lead counsel, Proskauer Rose. It asks for $23.2 million in fees, with objections due December 7 Dkt. 3779. A motion hearing is set for December 10, 2026.
Genesis and 298 affiliates filed in the Northern District of Texas on July 9 and 10, 2025, and the cases are jointly administered Dkt. 51. At filing the company ran about 175 skilled nursing and senior living facilities in 18 states, with more than 27,000 employees and 15,000 residents whyy.org: Genesis HealthCare rehab and nursing home operator files for bankruptcy (WHYY, 2025-07) (outside source). It entered the case with a stalking horse bid from an affiliate of ReGen Healthcare, its controlling investor Dkt. 18. The court rejected that insider sale in December 2025 skillednursingnews.com: Nursing Home Giant Genesis Faces New Auction After Judge Blocks PE Deal (Skilled Nursing News, 2025-12) (outside source), and a second auction produced the State Street deal. The incumbent DIP lenders kept control of the financing after a third-party lender offered to replace them. The case also drew congressional scrutiny of how Genesis treated malpractice and wrongful death claimants warren.senate.gov: Warren, Blumenthal, Welch, Goodlander Investigate Genesis HealthCare Private Equity Bankruptcy (Senator Warren Press Release, 2025-10-08) (outside source).
The confirmed plan sells the business and leaves unsecured creditors a liquidation trust
The debtors filed their first joint plan on May 11, 2026 with two tracks. The main track was a sale of substantially all assets to 101 W. State Street Holdings. If the purchase agreement terminated, the business would instead restructure, keep operating and issue a $289.1 million seven-year term loan note at 14% cash interest Dkt. 2693. Amended versions followed on July 27 and July 30 Dkt. 3066. On August 4, 2026 the court approved the disclosure statement, set September 21 as the deadline for ballots and confirmation objections, and scheduled the confirmation hearing for October 6 Dkt. 3101.
The second amended plan, filed October 4, added the $150 million settlement. It also added a channeling injunction for administrative personal injury and general liability (PL/GL) claims that participate in a dedicated fund, and mutual releases with stated exceptions Dkt. 3550. The modified plan filed October 11 provides for a $24 million contribution to that fund after the settlement. The debtors reported in that filing that no restructuring toggle notice had been filed, so confirmation went forward on the sale path. The releases preserve D&O claims against David Harrington, Jonathan Kirschner and John Randazzo Dkt. 3635. For Genesis PM PA Operations LLC, confirmation is conditioned on a judgment and final order in the PA-22 adversary proceeding, or a written settlement with Altira Health Group and OPA OpCo Parent Dkt. 3550.
Creditors voted on recovery estimates in the July 30 disclosure statement, which predate the $150 million settlement. The operating-facility group, Class 6-A, had the widest projected range, about $3.2 million to $109.8 million in dollar terms. In the disclosure statement's chapter 7 sale scenario, general unsecured creditors would recover 0% to 4.0% if the WAX and MAO claims stood and 4.7% to 12.3% if those claims were subordinated Dkt. 3070.
| Class | Claims | Estimated recovery |
|---|---|---|
| 1 | Prepetition ABL | 100% |
| 5-A | Welltower and Omega term loans | 100% |
| 5-B | WAX and MAO term loans (disputed) | 0% to 100% |
| 6-A | General unsecured, OpCo facility debtors | 0.6% to 20.9% |
| 6-B | General unsecured, ancillary business and JV debtors | 0.1% to 10.5% |
| 6-C | General unsecured, HoldCo non-facility debtors | 0.3% to 6.3% |
| 6-D | General unsecured, DivestCo debtors | 1.2% to 12.7% |
| 7 | WAX and MAO unsecured notes (disputed) | 0% to 0.3% |
| 8 | Convenience claims | About 46% |
| 9 and 11 | Subordinated claims, including ReGen notes; existing equity | 0% |
A second auction replaced the insider bid with State Street
Genesis entered chapter 11 with a stalking horse bid for substantially all assets from CPE 88988 LLC, an affiliate of ReGen Healthcare, which already controlled the company. A Special Investigation Committee of independent directors negotiated the bid. Advised by Katten Muchin Rosenman, the committee also investigated the claims the bid would purchase or release Dkt. 18. ReGen's founder, Joel Landau, sought releases from liability as a condition of the purchase. ReGen is affiliated with Pinta Capital Partners skillednursingnews.com: Nursing Home Giant Genesis Faces New Auction After Judge Blocks PE Deal (Skilled Nursing News, 2025-12) (outside source).
The debtors filed their bidding procedures motion on July 15, 2025 Dkt. 117, and the court entered the bidding procedures order on August 28, 2025 Dkt. 685. The final DIP order required an auction by November 13 and a sale order by November 18, 2025 Dkt. 677. The creditors' committee, formally the Statutory Unsecured Claimholders' Committee, challenged the timetable from the start. In August it asked the court to adjourn the hearing on the DIP and bidding procedures. It argued that the expedited schedule favored an insider sale, that the stalking horse purchase agreement had been filed 19 days late, and that third-party lenders were ready to offer better DIP terms Dkt. 478.
Objections increased before the December 10–11, 2025 sale hearing. The committee objected to the sale, and the U.S. Trustee's Office raised concerns about the auction. Senators Elizabeth Warren, Richard Blumenthal and Peter Welch and Representative Maggie Goodlander filed a brief supporting the creditor objections warren.senate.gov: Warren, Blumenthal, Welch, Goodlander Investigate Genesis HealthCare Private Equity Bankruptcy (Senator Warren Press Release, 2025-10-08) (outside source). After the hearing Judge Jernigan rejected the sale. She found "too many irregularities" in the auction and refused to approve the releases Landau had sought skillednursingnews.com: Nursing Home Giant Genesis Faces New Auction After Judge Blocks PE Deal (Skilled Nursing News, 2025-12) (outside source). She ordered a new auction for January 2026, which Skilled Nursing News reported would run under U.S. Trustee oversight. KFF Health News wrote that the ruling gave victims' families "fresh hope of compensation" kffhealthnews.org: Judge in Nursing Home Bankruptcy Case Gives Families Fresh Hope of Compensation (KFF Health News, 2025-12) (outside source).
On January 7, 2026, the court authorized the estate broker to designate Genie 3 Partners, LLC as replacement stalking horse and approved a break-up fee and expense reimbursement for it. Genie 3's agreement required its initial investors to put in at least $120 million of cash and included a four-year note at 3% interest Dkt. 2060. The debtors marketed the business to 252 potential buyers, 97 of whom signed NDAs. After five rounds of bidding, 101 W. State Street Holdings was named successful bidder, with Genie 3 as backup. The court approved the State Street sale on January 20, 2026 and entered the sale order on January 26. The purchase agreement, dated January 23, was amended and restated on April 17, 2026 Dkt. 3070.
- Cash sale proceeds$343.0M
- ABL facility assumed or refinanced$279.3M
- Promissory note$99.9M
- Projected cash on hand at closing$80.7M
- Bold Quail joint venture proceeds$57.5M
- Kennett Square sale$5.0M
Show the numbers
| Component | Amount |
|---|---|
| Cash sale proceeds | $343.0M |
| ABL facility assumed or refinanced | $279.3M |
| Promissory note | $99.9M |
| Projected cash on hand at closing | $80.7M |
| Bold Quail joint venture proceeds | $57.5M |
| Kennett Square sale | $5.0M |
| Total | $865.4M |
Source: declaration of Narendra Ganti, FTI Consulting Dkt. 2353
On that valuation, FTI put prepetition secured claims at $520.8 million to $605.3 million. The range depended on whether the $84.5 million of WAX and MAO term loan claims that the committee disputed were allowed. That left the secured lenders an equity cushion of 21.0% to 40.3% Dkt. 2353.
The sale needed further amendment before closing. On October 8, 2026 the court approved an amended purchase agreement and found that it had been negotiated in good faith, at arm's length and without collusion. The order required the debtors to dismiss the adversary proceeding with the buyer, with prejudice, within three business days after closing. The amended agreement set closing for October 9, subject to conditions, with the first-phase facilities transferring operations to new operators at closing Dkt. 3614. Counsel to patient care ombudsman Suzanne Koenig reports that the sale closed on October 14, 2026 Dkt. 3776. The disclosure statement had estimated about $35 million of potential transaction fees for Houlihan and Jefferies if the sale closed Dkt. 3070.
| Item | Terms |
|---|---|
| Cash consideration | $343 million less $10 million, with adjustments including $17.313 million of PA-22 cash consideration, interim financing costs and a payroll true-up |
| White Oak ABL facility | Refinanced by the buyer |
| Promissory note | $89.5 million |
| Settlement promissory note | $29,288,362.50 |
| Deposit | $54.3 million |
| Rochester Manor HUD loan | Assumed, up to $8.3 million |
| Priority tax claims | Assumed, up to $31,342,677.60 plus qualifying interest or penalties |
| Secured IRS claims | Assumed, up to $90 million, if a specified agreement fails |
| Postpetition bed taxes | Assumed, up to $47.5 million |
| Specified employee obligations | Assumed, up to $91 million |
| Cure costs | Paid in cash outside the price, capped at 115% of the stated cure amount |
The incumbent lenders kept the DIP after JMB offered to replace them
Before the filing, Jefferies approached 12 potential third-party lenders, and nine signed NDAs. The only indicative proposal required a senior priming lien, which the prepetition secured parties refused to accept Dkt. 19. The debtors instead took a $30 million junior secured DIP from three of their term loan lenders: Markglen (a Welltower affiliate), OHI Mezz Lender (Omega) and CPE 88988 LLC. The DIP papers identify CPE 88988 with WAX, and the first-day declaration identifies it as the ReGen affiliate that made the stalking horse bid. Welltower OP LLC served as agent. The court authorized $12 million on an interim basis on July 11, 2025 Dkt. 57. The DIP motion Dkt. 17 was granted on a final basis on August 28, 2025. The final order set 14% interest, a 2% upfront fee paid in kind, a 4% cash exit fee and a February 4, 2026 maturity. It gave the committee until October 13, 2025 to challenge prepetition liens, with a $250,000 investigation budget Dkt. 677.
By January 2026 the debtors forecast no further DIP draws, with cash falling from $65.2 million to $57.9 million over six weeks Dkt. 2035. On February 19, 2026, with the February 4 maturity already passed, the debtors moved for an $80 million replacement DIP from JMB Capital Partners Lending at 12% cash interest. It would have repaid the existing facility and primed the prepetition term loan lenders Dkt. 2331. The committee joined the motion. Its financial adviser stated that about $20.0 million of interest, adequate protection payments and fees had been incurred on the original DIP, roughly 67% of the facility's size Dkt. 2353.
Five days later the debtors filed an alternative motion to amend and extend the existing facility with the incumbent lenders Dkt. 2356. The court entered that order on March 2, 2026, authorizing up to $105 million. That was an $80 million initial commitment plus a $25 million incremental commitment if the Bold Quail settlement was not approved by April 15, 2026 Dkt. 2393. The debtors then asked to pay JMB a $1.6 million commitment fee. They argued that JMB's proposal had created the competition that pushed the existing lenders to improve their terms Dkt. 2455. After an April 8 hearing, the court denied the request on April 20, 2026 Dkt. 2615. The plan required DIP claims to be paid in full in cash at effectiveness Dkt. 3066, and the facility ended when the plan took effect on October 23, 2026.
ABL and term loans ranked ahead of $346 million of MAO and WAX notes and ReGen's subordinated notes
Genesis had 21 funded-debt instruments at the petition date. The 20 with a stated balance account for identified debt of about $1,103.7 million. The Change Healthcare advances have no stated amount, so that figure is not a complete total. The debtors also reported $708.5 million of secured liabilities, including $103.1 million of IRS tax liens for deferred payroll taxes Dkt. 18. They reported about $1.568 billion of unsecured liabilities, including $339.4 million of accounts payable, $266.2 million of accrued expenses and $259 million of estimated litigation claims Dkt. 3070.
- Secured
- Unsecured
- Subordinated
- Prepetition term loans (Welltower, Omega, WAX, MAO)Secured$317.8M
- White Oak Non-HUD ABL revolverFirst lien$223.6M
- White Oak HUD ABL revolverFirst lien$55.7M
- Rochester Manor HUD mortgageSecured$8.3M
- MAO and WAX unsecured notes (12% PIK)Unsecured$346.0M
- HCSG noteUnsecured$21.6M
- Medline noteUnsecured$15.0M
- LGO noteUnsecured$4.4M
- First ReGen noteSubordinated$50.0M
- Fourth ReGen note (with PIK interest)Subordinated$36.2M
- Third ReGen noteSubordinated$15.0M
- Second ReGen noteSubordinated$10.0M
Show the numbers
| Instrument | Rank | Balance |
|---|---|---|
| Prepetition term loans (Welltower, Omega, WAX, MAO) | Secured | $317.8M |
| White Oak Non-HUD ABL revolver | First lien | $223.6M |
| White Oak HUD ABL revolver | First lien | $55.7M |
| Rochester Manor HUD mortgage | Secured | $8.3M |
| MAO and WAX unsecured notes (12% PIK) | Unsecured | $346.0M |
| HCSG note | Unsecured | $21.6M |
| Medline note | Unsecured | $15.0M |
| LGO note | Unsecured | $4.4M |
| First ReGen note | Subordinated | $50.0M |
| Fourth ReGen note (with PIK interest) | Subordinated | $36.2M |
| Third ReGen note | Subordinated | $15.0M |
| Second ReGen note | Subordinated | $10.0M |
A set of intercreditor and subordination agreements governs lien priority among the secured lenders. White Oak Healthcare Finance, LLC holds first-priority liens on receivables through the two ABL revolvers. The term loan lenders, affiliates of Welltower, Omega, WAX and MAO, hold security interests in the company's remaining assets, including equity interests in joint ventures. Welltower and Omega held about $234 million of the term loans. The amended disclosure statement puts the WAX and MAO tranches at $84.9 million of petition-date principal Dkt. 3070.
The MAO and WAX unsecured notes come from loan agreements that certain debtors signed with a Welltower affiliate on December 22, 2016. Those loans were secured at the time by real estate the company no longer owns. In September 2024, Welltower assigned about $320 million of the obligations to MAO and the remaining $26.5 million to WAX. About $346 million was owed at the petition date, accruing 12.0% interest paid in kind Dkt. 18 · p. 38.
ReGen's four convertible subordinated notes were issued by FC-GEN Operations Investment, LLC: $50 million on March 2, 2021, $10 million on December 2, 2022, $15 million on January 4, 2023 and $25 million on May 24, 2023. The first three bear 1% annual interest payable at maturity. The fourth bears 1.5% a month paid in kind Dkt. 2693 · p. 33, which is why its petition-date balance was $36.2 million. If fully converted, the notes would give ReGen about 93% of the voting shares Dkt. 18.
The IRS asserted $118.5 million of claims, including $33.2 million secured and $76.3 million priority unsecured, related to deferred payroll taxes Dkt. 2694. Under the plan, the court sets the allowed amount of the IRS secured claims. The buyer pays them in equal annual installments over no more than seven years, capped at $90 million, and the debtors or the Liquidation Trust pay any excess Dkt. 3066.
The WAX and MAO positions were the contested layer. The WAX/MAO adversary proceeding challenged about $84.9 million of secured term loans and $346 million of unsecured notes. Dismissal was denied on May 19, 2026, and trial was set for August 17, 2026 Dkt. 3070. The second amended plan resolves the term loan piece by cancelling those claims without distribution once the sale closes Dkt. 3550.
Sale-leasebacks and acquisitions left Genesis a tenant carrying a larger company's liabilities
Genesis dates to 1985, when Michael Walker and Richard Howard acquired nine skilled nursing facilities. Acquisitions took revenue to $2.4 billion by 1998. Medicare cuts under the Balanced Budget Act of 1997 pushed the company into its first chapter 11 in 2000, and it emerged in 2001. In 2003 it spun off its pharmacy division, which adopted the NeighborCare name, and the skilled nursing operations became Genesis HealthCare Corporation.
Formation Capital era, 2007 to 2021
In July 2007, Genesis HealthCare Corporation merged with FC-GEN Acquisition, Inc. in a leveraged buyout valued at about $1.52 billion, led by affiliates of Formation Capital, LLC and JER Partners prnewswire.com: merged with FC-GEN Acquisition, Inc. (outside source). The portfolio then had 180 owned and leased facilities with more than 21,800 beds.
On April 1, 2011, Genesis transferred substantially all of its real property to Health Care REIT, Inc. (now Welltower) for $2.4 billion. The deal covered 147 facilities in 11 states and turned the owner-operator into a tenant under master leases on its former real estate. A Private Equity Stakeholder Project report alleges that Formation Capital used "leveraged buyouts, sale-leaseback transactions and layered debt to extract value" from Genesis and describes "asset stripping, high-risk borrowing, and recurring regulatory violations" pestakeholder.org: Genesis Healthcare files for bankruptcy (outside source).
In December 2012 Genesis acquired Sun Healthcare Group, Inc. skillednursingnews.com: Genesis HealthCare Files For Chapter 11 Bankruptcy (Skilled Nursing News, 2025-07) (outside source), reaching more than 400 facilities in 29 states. The February 2015 merger with Skilled Healthcare Group, Inc. made it the largest skilled nursing operator in the United States, with more than 500 facilities. At its 2016 peak it had more than 60,000 licensed beds in more than 30 states.
ReGen era, 2021 onward
The COVID-19 pandemic weakened Genesis's finances, and by late 2020 the company was preparing for chapter 11. A capital infusion from ReGen Healthcare and a master lease restructuring with Welltower kept it out of bankruptcy in March 2021. ReGen put in about $100 million through four convertible notes from 2021 to 2023 and appointed three directors, including the chairman Dkt. 18. Joel Landau, ReGen's founder and owner, became the controlling force behind the company. When ReGen first invested, Genesis also agreed to terminate its master lease on 51 Welltower facilities and transition them to new operators. It voluntarily delisted from the NYSE, and its stock moved to over-the-counter trading. The company shed facilities but kept liabilities tied to them.
Footprint
At filing, Genesis operated about 175 facilities in 18 states, mainly in the Northeast and Mid-Atlantic. New Hampshire alone had 16 Genesis nursing homes, and concerns about "instability" at them prompted state scrutiny nhpr.org: Genesis HealthCare declares bankruptcy, prompting concerns of 'instability' at its NH nursing homes (New Hampshire Public Radio, 2025-07-31) (outside source). Its ancillary businesses include Powerback Rehabilitation, LTC ACO and AlignMed. By the July 2026 disclosure statement, Genesis reported 168 licensed facilities in 16 states, more than 16,000 daily residents and more than 25,000 employees. Powerback Rehabilitation had $482 million of 2025 revenue and LTC ACO had $130 million Dkt. 3070.
Quality ratings
According to congressional investigators, the share of Genesis facilities rated above average (four or five stars) by the Centers for Medicare & Medicaid Services fell from 38% to 15% between ReGen's 2023 investment and the bankruptcy filing warren.senate.gov: Warren, Blumenthal, Welch, Goodlander Investigate Genesis HealthCare Private Equity Bankruptcy (Senator Warren Press Release, 2025-10-08) (outside source).
Tort costs of $8 million a month and legacy liabilities drove the filing
The first-day declaration of co-chief restructuring officer Louis E. Robichaux IV of Ankura Consulting Group sets out several connected causes. Despite $100 million of ReGen capital since 2021, the debtors could not reach an out-of-court deal with their term loan lenders Dkt. 18.
Pandemic aftereffects
The declaration states that "the after-effects of the pandemic on the skilled nursing industry generally, and Genesis HealthCare specifically, cannot be overstated." COVID-19 raised costs for labor, supplies and protective equipment. Reliance on staffing agencies pushed up labor, already the largest expense. Postponed elective procedures at nearby hospitals reduced referrals.
Medicaid reimbursement
Executives cited low state Medicaid rates, particularly in Pennsylvania and New Jersey. Pennsylvania, where Genesis is headquartered, is its fourth-largest unsecured creditor, with about $58 million in unpaid tax claims penncapital-star.com: Pa. nursing home operator Genesis enters bankruptcy with $58 million tax debt to state (Pennsylvania Capital-Star, 2025-07) (outside source).
Legacy liabilities
As Genesis cut its lease portfolio from more than 500 facilities to about 175, it remained liable for corporate guarantees, cross-collateralization and legacy liabilities from the larger footprint, some dating back decades. The amended disclosure statement adds negative free cash flow, interest, capital spending, IRS installments and Change Healthcare repayments to the list Dkt. 3070.
Litigation costs
Before the filing, Genesis was spending about $8 million a month to defend and settle malpractice and wrongful death lawsuits. Many of the claims predate the pandemic and involve facilities the company no longer operates.
| Measure | Amount |
|---|---|
| Pending lawsuits | More than 200 (malpractice and wrongful death) |
| Estimated litigation claims | $259 million Dkt. 18 |
| Estimated total debts to victims, per experts cited by Skilled Nursing News | Up to $344 million skillednursingnews.com: Nursing Home Giant Genesis Allegedly Delayed Millions in Settlements Ahead of Bankruptcy (Skilled Nursing News, 2025-12) (outside source) |
| Monthly defense and settlement costs | About $8 million |
Delayed settlement payments to victims drew congressional scrutiny
A CBS News investigation reported that in the years before the bankruptcy, Genesis settled at least 155 patient injury and death lawsuits on delayed payment terms, some allowing more than a year before payment was due. At filing, Genesis still owed $41 million of the $58 million it had promised plaintiff families under settlement agreements cbsnews.com: How delays and bankruptcy let a nursing home chain avoid paying settlements for injuries and deaths (CBS News, 2025-12) (outside source). Critics argue that the payment timing reduced what claimants received before the filing.
Congressional response
Senators Warren, Blumenthal and Welch and Representative Goodlander opened an inquiry in October 2025. They noted that ReGen's $100 million investment, convertible into about 93% of the equity and carrying three board seats, coincided with the decline in quality ratings. In a November 12, 2025 letter to the Acting Director of the Executive Office for U.S. Trustees, they asked whether Genesis was "exploiting the bankruptcy system" to avoid paying victims and families warren.senate.gov: Warren, Lawmakers Urge U.S. Trustee to Investigate Whether Genesis Healthcare Is Abusing the Bankruptcy System (Senator Warren Press Release, 2025-11-12) (outside source).
Claimant appeals were dismissed by stipulation, and the trust now contests late claims
About 200 plaintiffs with pending malpractice and wrongful death claims sought relief from the automatic stay, many within weeks of the petition date. The claims span states where Genesis operates or used to operate, including New Mexico, Kentucky and West Virginia, which the first-day declaration identifies as having "limited or no tort reform." The debtors moved in September 2025 to extend the stay, and personal injury claimants opposed, arguing they should be allowed to pursue insurance and other sources. Creditors also objected to the debtors' request to extend plan exclusivity. In December 2025, just before the sale hearing, the debtors and the committee filed cross-motions for sanctions and to compel discovery.
The Special Investigation Committee valued viable fraudulent transfer and fiduciary duty claims at about $34.54 million to $77.85 million, with a midpoint present value of about $32 million after fees. The creditors' committee asserted potential claims of more than $100 million, and the defendants disputed the allegations Dkt. 3070. The July plan assigned the committee's draft complaint, the WAX/MAO complaint and the PA-22 adversary proceeding to the Liquidation Trust Dkt. 3066. The October plan's mutual releases apply subject to their stated exceptions Dkt. 3635.
In late March 2026, groups of malpractice and wrongful death claimants took appeals to the U.S. District Court for the Northern District of Texas. On March 25, two amended notices of appeal were docketed. One was filed by claimants represented by Rochelle McCullough, LLP, Reddick Law Firm, P.A. and Hughes & Coleman Injury Lawyers. The other was filed for the estates of deceased residents, including the Estates of Alma Brown, Andrea Dominquez and Don Arrington, and for claimant Delores Buckner. The appellants designated the record on appeal on March 30. On October 14, 2026, District Judge Brantley Starr dismissed the appeal in Civil Action 3:26-cv-00962-X without prejudice on the parties' joint stipulation, each side bearing its own fees and costs Dkt. 3661. PACS Group, Inc. and Providence Administrative Consulting Services, Inc. moved for stay relief on March 26, 2026.
Since effectiveness the Liquidation Trust has taken over claim objections. In its November 13 objection, the trust says the claimant alleges injuries at a debtor facility in December 2024. She sued on February 19, 2026, received the debtors' suggestion of bankruptcy six days later, and filed her proof of claim on October 23, 2026, the effective date. The trust argues she has not shown the excusable neglect needed to allow a late claim and asks the court to deny her motion Dkt. 3771. Claims are also still trading. On November 16, VonWin Trust LP gave notice that it had acquired a claim from Shawe & Rosenthal LLP, listed at $73,204.38 Dkt. 3774.
Committee lead counsel's $23.2 million leads the final fee requests
| Role | Professional |
|---|---|
| Debtors' counsel | McDermott Will & Emery LLP |
| Debtors' investment banker | Jefferies LLC |
| Co-chief restructuring officers | Louis E. Robichaux IV and Russell A. Perry, Ankura Consulting Group, LLC |
| Claims and noticing agent | Epiq Corporate Restructuring, LLC |
| Counsel to the independent directors and Special Investigation Committee | Katten Muchin Rosenman LLP |
| Committee lead counsel | Proskauer Rose LLP |
| Committee local counsel | Stinson LLP |
| Committee financial advisor | FTI Consulting, Inc. |
| Committee investment banker; estate broker | Houlihan Lokey Capital, Inc. |
| Counsel to CPE (ReGen) | DLA Piper |
Three patient care ombudsmen monitored the facilities. Susan N. Goodman covered California, New Mexico, Washington and West Virginia Dkt. 3757. Melanie L. Cyganowski served with Otterbourg P.C. as counsel Dkt. 3769. Suzanne A. Koenig covered Alabama, Delaware, Maryland, North Carolina, Tennessee, Virginia and Pennsylvania, with Greenberg Traurig as counsel and SAK Healthcare as medical operations advisor. Koenig's appointment ended when the sale closed on October 14, 2026, after her seventh and final report Dkt. 3776. Her last reports also dealt with custody of, and access to, medical records as facilities changed hands. SAK Healthcare filed a fifth interim application on November 16 for $510,830 of fees and $27,142.39 of expenses for July through September 2026 Dkt. 3778. Goodman filed a third report in December 2025, covering October 15 through December 13, 2025, and a further report on March 27, 2026. Cyganowski filed the fourth ombudsman report on March 30, 2026. The independent directors whose counsel seeks final fees are Jonathan Foster and Elizabeth LaPuma Dkt. 3767.
| Applicant | Role | Fees requested | Objections due |
|---|---|---|---|
| Proskauer Rose LLP | Committee lead counsel | $23,228,037.50 Dkt. 3779 | December 7, 2026 |
| Katten Muchin Rosenman LLP | Counsel to the independent directors | $6,010,320.00 Dkt. 3767 | Not stated |
| Stinson LLP | Committee local counsel | $5,349,645.00 Dkt. 3764 | December 1, 2026 |
| Greenberg Traurig, LLP | Counsel to ombudsman Koenig | $1,045,864.00 Dkt. 3776 | December 16, 2026 |
| Melanie L. Cyganowski and Otterbourg P.C. | Ombudsman and counsel | $636,832.80 Dkt. 3769 | December 12, 2026 |
| Susan N. Goodman | Ombudsman | $629,365.00 Dkt. 3757 | November 30, 2026 |
Proskauer's final request includes $17.77 million of fees the court already allowed on an interim basis across four applications. It asks for payment of $10.54 million of allowed amounts not yet paid and reports $1.27 million of voluntary write-offs Dkt. 3779. Stinson asks that its allowed but unpaid amounts be paid from the professional fee escrow account by the post-restructuring debtors or the wind-down trustee Dkt. 3764.
Genesis filed during a two-year high in senior care bankruptcies
Senior Housing News reported that senior care bankruptcy filings rose from three in the fourth quarter of 2024 to seven in the first quarter of 2025, a two-year high and more than 40% of all healthcare bankruptcy filings seniorhousingnews.com: Senior Housing News - Inside the Financial, Human Impact of Senior Living's Bankruptcy Trend (outside source). Bloomberg Law reported that 774 nursing homes have closed since 2020, removing 62,567 beds and displacing 28,421 residents news.bloomberglaw.com: Nursing Homes Shrouded by Regulatory Changes, Financial Strain (Bloomberg Law, 2025) (outside source).
| Metric | Value |
|---|---|
| Senior care bankruptcies, Q1 2025 | 7 (vs. 3 in Q4 2024) |
| Senior care share of healthcare filings, Q1 2025 | More than 40% |
| Nursing home closures since 2020 | 774 |
| Beds lost since 2020 | 62,567 |
| Residents displaced since 2020 | 28,421 |
| SNF and senior care bankruptcies since 2020 with liabilities above $10 million | More than 135 |
Industry representatives point to Medicaid rates that do not cover the cost of care, post-pandemic workforce shortages, regulatory burden and litigation exposure. An ACPlus analysis warns that the One Big Beautiful Bill Act will cut nearly $1 trillion from Medicaid and that nursing homes could face $500 billion in Medicare sequestration cuts from 2026 to 2034 acplus.com: 2025 Skilled Nursing Facility Industry Outlook (ACPlus, 2025) (outside source).
The case ran fifteen months from petition to effectiveness
| Date | Event |
|---|---|
| 1985 | Genesis Health Ventures founded with nine facilities |
| 2000 | First chapter 11 filing; emerged in 2001 |
| July 2007 | Formation Capital and JER Partners leveraged buyout, valued at about $1.52 billion |
| April 1, 2011 | Sale-leaseback of 147 facilities to Health Care REIT (Welltower) for $2.4 billion |
| December 2012 | Sun Healthcare acquisition |
| February 2015 | Skilled Healthcare merger |
| March 2021 | First ReGen note ($50 million); NYSE delisting |
| December 2022 to May 2023 | Second through fourth ReGen notes ($50 million combined) |
| July 9–10, 2025 | Chapter 11 petitions for 299 debtors |
| July 11, 2025 | Joint administration order; interim DIP order |
| August 28, 2025 | Final DIP order; bidding procedures order |
| October 31, 2025 | General claims bar date |
| November 12, 2025 | Congressional letter to the Executive Office for U.S. Trustees |
| December 10–11, 2025 | Sale hearing; court rejects insider sale and orders a new auction |
| January 7, 2026 | Genie 3 Partners designated replacement stalking horse |
| January 20 and 26, 2026 | State Street sale approved; sale order entered |
| February 19, 2026 | Debtors move for $80 million JMB replacement DIP |
| March 2, 2026 | Incumbent DIP amended and extended to up to $105 million |
| March 25–30, 2026 | Claimant appeals docketed in district court; record designated |
| April 17, 2026 | Purchase agreement amended and restated |
| April 20, 2026 | JMB commitment fee denied |
| May 11, 2026 | Initial plan and disclosure statement filed |
| May 19, 2026 | Dismissal of WAX/MAO adversary proceeding denied |
| August 4, 2026 | Disclosure statement approved |
| September 21, 2026 | Voting and confirmation objection deadline |
| October 4, 2026 | Second amended plan with $150 million settlement filed |
| October 8, 2026 | Amended purchase agreement approved |
| October 14, 2026 | Plan confirmed; sale closes; plan takes effect for ACO entities; claimant appeal dismissed |
| October 23, 2026 | Plan takes effect for all remaining debtors; equity cancelled |
| November 10–16, 2026 | Final fee applications filed by committee counsel, the independent directors' counsel and ombudsman professionals |
| November 13, 2026 | Liquidation Trust objects to late claim; administrative claims bar date for ACO entities |
| November 23, 2026 | Administrative claims bar date for remaining debtors |
| December 7, 2026 | Objection deadline for Proskauer's final fee application |
| December 10, 2026 | Motion hearing |
| December 22, 2026 | Final professional fee applications due |
Sources
- Dkt. 17Genesis Healthcare DIP MotionFiled Jul 10, 2025Jul 10, 2025
- Dkt. 18Declaration in Support of First Day PleadingsCited at p. 38 · Filed Jul 10, 2025Jul 10, 2025
- Dkt. 19DIP Financing DeclarationFiled Jul 10, 2025Jul 10, 2025
- Dkt. 51Order Directing Joint AdministrationFiled Jul 11, 2025Jul 11, 2025
- Dkt. 57Interim DIP and Cash Collateral OrderFiled Jul 11, 2025Jul 11, 2025
- Dkt. 117Bidding Procedures and Stalking Horse MotionFiled Jul 15, 2025Jul 15, 2025
- Dkt. 478Committee Motion to Adjourn DIP and Bidding HearingsFiled Aug 18, 2025Aug 18, 2025
- Dkt. 677Genesis HealthCare Final DIP OrderFiled Aug 28, 2025Aug 28, 2025
- Dkt. 685Bidding Procedures and Sale OrderFiled Aug 28, 2025Aug 28, 2025
- Dkt. 2035Notice of Updated DIP BudgetFiled Jan 5, 2026Jan 5, 2026
- Dkt. 2060Genie 3 Replacement Bidder OrderFiled Jan 7, 2026Jan 7, 2026
- Dkt. 2331Genesis Healthcare DIP Financing MotionFiled Feb 19, 2026Feb 19, 2026
- Dkt. 2353Declaration Supporting Replacement DIP FinancingFiled Feb 24, 2026Feb 24, 2026
- Dkt. 2356Genesis Healthcare DIP Financing MotionFiled Feb 24, 2026Feb 24, 2026
- Dkt. 2393Final DIP and Cash Collateral OrderFiled Mar 2, 2026Mar 2, 2026
- Dkt. 2455Motion to Pay JMB Commitment FeeFiled Mar 16, 2026Mar 16, 2026
- Dkt. 2615Order Denying Commitment Fee PaymentFiled Apr 20, 2026Apr 20, 2026
- Dkt. 2693Genesis Healthcare Joint Chapter 11 PlanCited at p. 33 · Filed May 11, 2026May 11, 2026
- Dkt. 2694Genesis Healthcare Disclosure StatementFiled May 11, 2026May 11, 2026
- Dkt. 3066Genesis Amended Chapter 11 PlanFiled Jul 30, 2026Jul 30, 2026
- Dkt. 3070Genesis Amended Disclosure StatementFiled Jul 30, 2026Jul 30, 2026
- Dkt. 3101Solicitation Plan ProposalFiled Aug 5, 2026Aug 5, 2026
- Dkt. 3550Genesis Two-Path PlanFiled Oct 4, 2026Oct 4, 2026
- Dkt. 3614APA Amendment ApprovalFiled Oct 8, 2026Oct 8, 2026
- Dkt. 3635Genesis Modified PlanFiled Oct 11, 2026Oct 11, 2026
- Dkt. 3661Appeal Dismissed Without PrejudiceFiled Oct 14, 2026Oct 14, 2026
- Dkt. 3662Genesis Plan ConfirmationFiled Oct 14, 2026Oct 14, 2026
- Dkt. 3667ACO Plan Effective DateFiled Oct 15, 2026Oct 15, 2026
- Dkt. 3702Plan Effective Date NoticeFiled Oct 23, 2026Oct 23, 2026
- Dkt. 3757Ombudsman Fee ApplicationFiled Nov 8, 2026Nov 8, 2026
- Dkt. 3764Stinson Fee ApplicationFiled Nov 10, 2026Nov 10, 2026
- Dkt. 3767Katten Fee ApplicationFiled Nov 11, 2026Nov 11, 2026
- Dkt. 3769Ombudsman Fee ApplicationFiled Nov 12, 2026Nov 12, 2026
- Dkt. 3771Trust Objects to Late ClaimFiled Nov 13, 2026Nov 13, 2026
- Dkt. 3774Claim Transfer NoticeFiled Nov 16, 2026Nov 16, 2026
- Dkt. 3776Combined Fee ApplicationFiled Nov 16, 2026Nov 16, 2026
- Dkt. 3778SAK Fifth Interim Fee ApplicationFiled Nov 16, 2026Nov 16, 2026
- Dkt. 3779Fifth and Final Fee ApplicationFiled Nov 16, 2026Nov 16, 2026
- WebGenesis HealthCare rehab and nursing home operator files for bankruptcy (WHYY, 2025-07)whyy.org · Outside source
- WebNursing Home Giant Genesis Faces New Auction After Judge Blocks PE Deal (Skilled Nursing News, 2025-12)skillednursingnews.com · Outside source
- WebWarren, Blumenthal, Welch, Goodlander Investigate Genesis HealthCare Private Equity Bankruptcy (Senator Warren Press Release, 2025-10-08)warren.senate.gov · Outside source
- WebJudge in Nursing Home Bankruptcy Case Gives Families Fresh Hope of Compensation (KFF Health News, 2025-12)kffhealthnews.org · Outside source
- Webmerged with FC-GEN Acquisition, Inc.prnewswire.com · Outside source
- WebGenesis Healthcare files for bankruptcypestakeholder.org · Outside source
- WebGenesis HealthCare Files For Chapter 11 Bankruptcy (Skilled Nursing News, 2025-07)skillednursingnews.com · Outside source
- WebGenesis HealthCare declares bankruptcy, prompting concerns of 'instability' at its NH nursing homes (New Hampshire Public Radio, 2025-07-31)nhpr.org · Outside source
- WebPa. nursing home operator Genesis enters bankruptcy with $58 million tax debt to state (Pennsylvania Capital-Star, 2025-07)penncapital-star.com · Outside source
- WebNursing Home Giant Genesis Allegedly Delayed Millions in Settlements Ahead of Bankruptcy (Skilled Nursing News, 2025-12)skillednursingnews.com · Outside source
- WebHow delays and bankruptcy let a nursing home chain avoid paying settlements for injuries and deaths (CBS News, 2025-12)cbsnews.com · Outside source
- WebWarren, Lawmakers Urge U.S. Trustee to Investigate Whether Genesis Healthcare Is Abusing the Bankruptcy System (Senator Warren Press Release, 2025-11-12)warren.senate.gov · Outside source
- WebSenior Housing News - Inside the Financial, Human Impact of Senior Living's Bankruptcy Trendseniorhousingnews.com · Outside source
- WebNursing Homes Shrouded by Regulatory Changes, Financial Strain (Bloomberg Law, 2025)news.bloomberglaw.com · Outside source
- Web2025 Skilled Nursing Facility Industry Outlook (ACPlus, 2025)acplus.com · Outside source